In various European countries there is anxiety about a possible link between animal spongioform encephalopathies and human encephalopathies, including Creutzfeldt-Jakob disease (CJD). The European collaborative study on CJD aims: (a) to study the frequency of human spongioform encephalopathies in Europe, in particular CJD, in relation to animal spongioform encephalopathies; and (b) to assess the risk of CJD and other human spongioform encephalopathies in relation to genetic, occupational, and nutritional factors.
The European study on animal spongioform encephalopathies and CJD will comprise three parts: (a) the establishment of registries of CJD cases in European countries; (b) a case-control study of risk factors for CJD on the basis of cases in the registries; (c) molecular genetic studies of CJD with material collected in the registries.
In a two year period 200 patients and 200 controls will be included in the collaborative case-control study. In the Dutch registry cases of CJD occurring in 1993 were ascertained. According to the diagnostic criteria for CJD there were 15 CJD cases in The Netherlands. Seven were classified as definite and eight probable between 1 January 1993 and 1 April 1994. The comparative incidence of CJD cases in France, Germany, Italy, The Netherlands, and the United Kingdom is similar, despite greater variation in the incidence of bovine spongioform encephalopathy. Familial hemiplegic migraine (FHM) is a rare subtype of migraine with aura, which displays autosomal dominant inheritance.
Identification of the FHM gene may help to unravel the pathogenesis of more common types of migraine. A linkage study has been started to identify the FHM gene.
Two unrelated multigenerational families displaying pure FHM with more than 240 microsatellite markers each were tested. These and three additional families were tested specifically for linkage to chromosome l9p markers.
Four of the five families had, as well as FHM, one or more family members with normal migraine with or without aura. Cosegregating symptoms were cerebellar ataxia in one and benign focal neonatal convulsions in another family. About 2800 cM of the total genome in each of the two pedigrees was excluded in the random gene search. Linkage to markers for chromosome l9pl3 locus was shown for three families; evidence against linkage was found in the two other families. Results of the two point and multipoint linkage analysis as well as the heterogeneity analysis will be discussed.
In some families, FHM is linked to chromosome l9pl3. Other gene loci also seem to be implicated. Clinical correlation to the linkage data and implications for the genetics of normal non-FHM migraine will be discussed. DOPPLER The detection of embolic materials with Doppler ultrasound, recently confirmed in experimental models, suggests a possible diagnostic role in patients at risk of embolism. Forty one patients with acute anterior circulation ischaemic stroke were studied within 48 hours of deficit; 27 patients with internal carotid artery (ICA) stenosis (21 symptomatic, studied 1-72 (median 4) months after deficit); and 30 healthy volunteers were also studied. In stroke cases, diagnostic subclassification was made from clinical, CT, and carotid and cardiac ultrasound data. In all cases, prolonged Doppler recordings were made from middle cerebral arteries (Nicolet TC2000, Warwick).
Emboli signals were detected in 29 of 41 cases of stroke (71%), 24 of 27 cases of ICA stenosis (89%), and none of 30 controls. There was a correlation between emboli signals and the site and type of underlying disease. In patients with unilateral ICA stenosis the embolic count was significantly higher in the ipsilateral middle cerebral artery than contralaterally (14 (10-22) v 2 (0-7) signals per hour, median (95% confidence interval) p < 0-0001). In patients with stroke, the emboli count was significantly higher in symptomatic than asymptomatic cerebral hemispheres (p < 0 05) . No emboli were found in eight cases of lacunar stroke.
Intracranial Doppler emboli signals are common in ICA stenosis and in large vessel and cardioembolic stroke. Their absence in lacunar stroke is in keeping with a small vessel aetiology. The Dysfunction of the CNS usually occurs early in the course of sepsis and is associated with a significantly increased mortality. This study was designed to study the changes in cerebral haemodynamics during Gram negative septic shock (GNSS).
During seven days transcranial Doppler (TCD) studies of blood flow velocities (BFVs) in the middle cerebral (MCA) and internal carotid artery (ICA) were performed in patients with GNSS and with decreased consciousness in the intensive care unit. The TCD data were analysed in relation to several biochemical and haemodynamic indices as to a score of illness (APACHE-II-score).
Fourteen patients (10 men, four women, mean age 58-4 (SD 6 8) years) were examined. A severe GNSS existed in all patients based on systemic haemodynamic indices. Eight patients survived, six died. TCD showed increased MCA-BFV especially in days 3 to 6; ICA-BFV was in the normal range over the whole period. The MCAIICA ratio was increased during the septic period. The mean MCA-BFV data correlated strongly with the APACHE-IIscore (r, = 0-81, p = 0 009).
In conclusion, a mild vasospasm of the basal cerebral arteries during these first seven days of sepsis could be demonstrated. Increased MCA-BFV is indicative for the severity of the disease. Non-survivors tended to have increased mean MCA-BFV but in this series did not reach significance. spin echo; (b) dynamic imaging during the passage of a gadolinium bolus. Six patients (five dural AVFs, one intramedullary AVM) and two controls have been studied. TI and T2 weighted sagittal images of the whole cord were obtained with a multiarray receiver coil. Sagittal gradient echo images (GE2425, flip angle 100) were then obtained at 3-5 second intervals after bolus injection of gadolinium-DTPA. Characteristic abnormalities were seen on high resolution images in all patients. In five, dynamic scanning showed transient signal reduction within the perimedullary venous plexus during bolus passage. The MRI findings correlated well with those from selective spinal angiography, the site of the arteriovenous shunt being localised to within one vertebral body in four patients.
With current MR imaging, myelography is probably unnecessary in the diagnosis of AVMs. Dynamic "blood flow" scanning is a useful adjunct to angiography as it may localise the site of an arteriovenous shunt. Clinical features and genetic analysis of a family with anaplastic ependymomas are described.
Four affected members within a single generation of a family were investigated, and the data concerning their relatives in several generations were collected. Tumour histology and immunohistochemistry were obtained in three patients. Genotype analysis (fluorescent in situ hybridisation, restriction fragment length polymorphism analysis, and RNA-SSCP analysis of the NF2 gene) was performed on one of the tumours.
Two healthy brothers each had two affected sons. All four boys presented before five years of age with intraventricular tumours (three infratentorial, one supratentorial). Two boys died before the age of 3. Neuroradiology, histology, and immunohistochemistry were similar in all tumours. Genetic analysis indicated monosomy of part of chromosome 22 in tumour cells. No mutations were found in the NF2 gene in tumour RNA.
In conclusion, a tumour suppressor gene on chromosome 22 may be involved in the pathogenesis of familial ependymal tumours.
The impact of radiotherapy on cognitive function and quality of life was studied in 41 long term (mean 3-5 years) survivors with biopsy-proved LGG and without signs of tumour recurrence. Twenty patients had been treated with early radiotherapy; the other 21 patients only had surgery or biopsy. Nineteen patients with low grade haematological malignancies, surviving one to 15 years without CNS involvement, served as controls. Apart from the neurological and functional status, the patients' cognitive, affective and psychosocial status were also determined.
None of the LGG survivors had significant neurological impairment and their Karnofsky index was at least 70. More specific examination of cognitive functions, however (for example memory, word fluency, and concentration), and the affective status (Profile of Mood States) indicated that, compared with the control subjects, the patients with LGGs had significantly more cognitive disturbances and often showed fatigue and depressed moods. The two LGG groups, on the other hand, did not differ significantly for any of these indices.
In conclusion, radiotherapy had no deleterious impact on cognitive function or quality of life in patients treated for LGGs. In an open study 25 patients with Guillain-Barre syndrome were treated for five days with intravenous immune globulins in a dose of 0-4 g per kg bodyweight per day and 0-5 g methylprednisolone intravenously per day. The results of this combined treatment were compared with the results from a group of 74 patients who were treated with immune globulins only in a recent Dutch Guillain-Barre trial.
In the methylprednisolone-immune globulin group 19 of 25 patients (76%) improved by one or more functional grades after four weeks, compared with 39 of 74 patients (53%) treated with immune globulin alone (p = 0 04). Also the median time required to reach the stage of walking independently was reduced in the methylprednisolone-immune globulin treatment group.
This pilot study suggests that combined treatment with methylprednisolone and immune globulin in patients with the Guillain-Barre syndrome is more effective than treatment with immune globulin alone. A randomised clinical trial might confirm this.
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The occurrence and the clinical and genetic variability of early onset facioscapulohumeral muscular dystrophy (FSHD) has been determined.
A group of 96 patients from 17 families with autosomal dominant FSHD, nine sporadic cases of FSHD, and 35 children at risk for having the FSHD gene were searched for the presence of early onset cases. Criteria for early onset FSHD were (a) signs or symptoms of facial weakness before the age of 5, and (b) signs or symptoms of shoulder girdle weakness before the age of 10 years.
Six early onset cases (four familial, two sporadic) were identified. Four out of five cases showed an abnormal DNA fragment with the probe p1 3E-1, which has been shown to detect DNA rearrangements in patients with FSHD. The clinical symptoms in these early onset cases showed great variability with respect to rate of progression of muscle weakness, the association of hearing loss and retinopathy, and the expression of the disorder in parents and siblings.
It has been suggested that infantile FSHD is a separate form of the disease, often accompanied by sensorineural hearing loss and retinal telangiectasia. These findings, as well as the recent discovery that both hearing loss and retinal vasculopathy are part of FSHD, suggest that early onset FSHD is not a separate entity, but part of a wide clinical spectrum of FSHD. Old age and bulbar onset are associated with a worse prognosis.
The geographic distribution was analysed in 367 patients and shows a significant inverse association with socioeconomic deprivation. A case-control study of 103 patients has shown no difference in social class in adult life or childhood and this pattern may be explained by underascertainment of older patients in less affluent areas. Cases were more likely to recall fractures before onset and occupational exposure to toxins but no single agent was implicated. Genetic factors are clearly implicated in the 25 patients (4 7%) with a family history of MND. Gompertzian analyses of agespecific incidence rates provide some evidence that sporadic MND also develops in a susceptible subgroup of the Scottish population. In three of the patients an ATT-ACT nucleotide substitution was detected in codon 113 of exon 4. This mis-sense mutation substitutes threonine for isoleucine and has been found in familial MND. A fourth patient had a novel glutamic acid to lysine mutation in codon 21 of exon 1. No mutations were detected in other exons, or in samples taken from 80 controls. The findings indicate that germline mutations may be a more common cause of sporadic MND than hitherto suspected and this has important implications for the counselling of the immediate families. They also support the hypothesis that MND is associated with abnormalities of free radical metabolism and mutations in other candidate genes are now being sought. Atypical forms of SBMA exist, however, which share many characteristics with Kennedy's disease. The clinical features of seven patients presenting with slowly progressive SBMA were evaluated and compared with those of three patients with Kennedy's disease. Also, the results of further investigations including endocrinological studies were evaluated. The androgen receptor gene was analysed for the length of the CAG repeat. The entire coding sequence was screened for mutations by means of single stranded conformation polymorphism (SSCP).
CU-ZN SUPEROXIDE DISMUTASE (SODI) MUTATIONS AND SPORADIC MOTOR NEURON
The age of onset, bulbar involvement, signs of reduced androgen sensitivity, cramps, fasciculations, tremor, plantar responses, benign course, EMG, SSEP, routine blood tests, and endocrinological tests did not differentiate Kennedy's disease from atypical SBMA. Site of onset, distribution of weakness, vibration sense, tendon reflexes of the lower limb, and pseudobulbar reflexes were helpful to distinguish atypical SBMA from Kennedy's disease. The androgen gene of the atypical SBMA patients had normal CAG repeat length and showed normal SSCP patterns, thus rendering any mutation within the coding sequence highly unlikely.
It is concluded that atypical SBMA is not caused by exonic mutations of the androgen receptor gene and can be differentiated from Kennedy's disease on clinical grounds. Oxygen free radical damage has been implicated in the pathogenesis of familial motor neuron disease (MND) in patients with mutations of the Cu/Zn superoxide dismutase (SODI) gene. At present the relevance of this important finding to sporadic MND remains unknown. Certain metals and trace elements may be linked with free radical pathways in the CNS. Selenium (Se) is an essential trace element and over 40% of the Se in mammalian brain is contained in the Se dependent enzyme glutathione peroxidase. This enzyme acts in concert with SODI forming a major part of the oxygen free radical detoxifying mechanism in neurons. Iron, in its ferrous form, is also a potential source of free radicals in biological systems.
RAISED SPINAL CONCENTRATIONS OF SELENIUM AND IRON AND GLUTATHIONE
The aim of this study was to compare bulk tissue concentrations of 10 elements in spinal cord tissue from MND and control cases by neutron activation analysis. Uncontaminated LI spinal cord samples were processed from 38 sporadic MND subjects and 22 controls.
There were significant increases in mean tissue concentrations of Se (p < 0-0001) and iron (p < 0 009) in the MND group. It is postulated that the increased Se in MND spinal cord might reflect upregulation of glutathione peroxide activity. Enzyme assays in an adjacent segment of spinal cord L3 showed that GP activity was greater in cases of MND than in controls (p < 0-001). These findings may be important in relation to oxygen free radical mechanisms of neuronal injury in sporadic MND. This study investigates the psychological and SPECT findings in 17 patients with classic MND. None of the patient group had clinical evidence of cognitive impairment. Psychological tests of language, perceptuospatial abilities, memory, and frontal lobe function were performed on patients and 10 controls. SPECT was performed with 99Tc-HMPAO. Mean regional cerebral blood flow indices (rCBFi) were calculated for the patient and control groups.
Psychological data showed significant group differences restricted to the scores of frontal lobe tests. SPECT group data showed significant reductions in mean rCBF, restricted to the orbitofrontal and anterior temporal cortices. This study shows subclinical evidence of frontal lobe dysfunction in classic MND. The pattern of psychological involvement and distribution of SPECT abnormality is qualitatively similar to that encountered in FTD and entirely consistent with the pathological findings in classic MND. This study reinforces the links between FTD, FTD with MND, and classic MND, which may represent a spectrum of the same disorder.
CORTICAL DYSPLASIA AND EPILEPSY S Sisodya, A Raymond, S Free, DR Fish, SD Shorvon. Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK Before MRI, no cause for epilepsy could be identified in about two thirds of all cases (idiopathic or cryptogenic epilepsy). With MRI, however, structural abnormalities are found in many previously cryptogenic patients, and cortical dysplasias form an important aetiological subgroup. The term cortical dysplasias refers to a spectrum of developmental anomalies due to abnormalities of neuronal migration during foetal development or to early (usually prenatal) cerebral insults. In this case series of chronic cryptogenic epilepsy, underlying lesions are found by MRI in about 80%, and cortical dysplasias account for 17%; 80 adults with epilepsy and cortical dysgenesis have now been identified, the commonest of which are subependymal heterotopias, other heterotopias, gyral anomalies (including macrogyria, polymicrogyria, lissencephaly, schizencephaly), and dysembryoplastic neuroepithelial tumours. The MRI methods that are particularly useful in detecting dysplasia include: volumetric TI weighted data acquisition, the use of thin contiguous slices (< 1-5 mm), multiplanar reformatting, 3D reconstruction, and the use of fluid attenuated inversion recovery. Other experimental techniques include fractal analysis, volume measures, and texture analysis. The cause of these conditions is largely unknown, but some (for instance subependymal heterotopia) show a striking female preponderance (12/13 cases) suggesting genetic factors; others had prenatal drug exposure. Epilepsy is often the only neurological symptom in these adult cases.
HYPEREKPLEXIA: CLINICAL AND GENETIC RELATIONSHIPS MAJ Tijssen, R Boerman, J van Deutekom, G Padberg, RR Frants, RAC Roos, JG van Dijk. Leiden University, The Netherlands Hyperekplexia or startle disease is an autosomal dominant disorder characterised by exaggerated startle reactions to unexpected stimuli, particularly auditory. Periodic limb movements in sleep and a pronounced head retraction reflex are additional findings. Both major and minor forms are recognised. The major form is characterised by excessive startle responses followed by stiffness, and stiffness in the neonatal period. In contrast, the minor form only shows an exaggerated startle reaction. Recently linkage was found to the markers D5S209 and D5S1l9 on chromosome 5q33-q35 in four pedigrees with autosomal dominant hyperekplexia. All patients in these pedigrees had the major form.
The original Dutch family has been reexamined; history was taken and neurological examination was performed. The relation between neglect phenomena in patients with first ever acute hemispheric stroke was assessed.
One hundred and twenty eight patients with stroke (67 left; 61 right) were tested in the acute phase for the presence of several neglect phenomena. Localisation and size of the lesion and premorbid atrophy were assessed by CT.
75% of the right hemisphere lesion group, and 61% of the left hemisphere lesion group manifested one or more neglect phenomena. All phenomena proved to be more frequent in the former group. A hierarchical order in the expression of the various phenomena was found: in nonsevere neglect only sensory inattention/ extinction and in more severe cases successively anosognosia, hypokinesia of the contralateral arm, motor extinction, disorders of the contralateral body scheme, verbal asomatognosia, and finally contralateral hypokinesia of the ipsilateral arm. In the patients who did not fully comply with the hierarchical order (n = 22), no alternative pattern could be ascertained. The number of neglect phenomena correlated with the size of the lesion and, independently, with premorbid atrophy. None of the phenomena was related to tension in a specific site.
It is concluded that neglect phenomena are part of one single syndrome. The severity of neglect evolves according to a hierarchical order within the phenomena of neglect. The severity of neglect is related to the size of the lesion and the degree of premorbid atrophy. PROTON We have carried out proton magnetic resonance spectroscopy (MRS) centred on the lentiform nucleus in eight patients with the predominantly striatonigral variant of MSA, nine patients with IPD, and eight age matched healthy controls. Spectra were collected with a STEAM sequence at an echo time of 270 ms.
The -MSA group had significantly lower NAA/creatine ratios (mean 1-28(SD 0 3)) compared with controls (1-8(SD 0-12), p = 0-001). By contrast the IPD group showed normal NAA/creatine ratios (1-79(SD 0 337), p > 0 5). The NAA/creatine ratio was significantly reduced in seven patients with MSA and only one patient with IPD. Also, the choline/creatine ratio was significantly reduced in the MSA group (1-025(SD 0-11)) compared with controls (1-22(SD 0-19), p < 0-01). The choline/creatine ratio showed no significant reduction in the IPD group (115, p < 0 5).
The reduction of the NAA/creatine ratio in the MSA group probably reflects neuronal loss, occurring predominantly in the putamen. The decreased choline/creatine ratio in the MSA group suggests a reduction in membrane turnover. Proton The preoperative identification of cerebral tumours remains a challenge. Proton magnetic resonance spectroscopy (MRS) detects at least nine cerebral metabolites, and is being increasingly used to investigate the biochemical changes accompanying neurological disease. The information obtained is often non-specific, however, providing perhaps prognostic data, but rarely a diagnosis.
In vivo short echo proton spectra (TE = 10 ms) obtained at 1-5 T from two patients with cerebral meningiomas showed an increase in the peak assigned to choline containing compounds, a reduction in that assigned to N-acetyl containing compounds, and a prominent resonance assigned to alanine, as has previously been described. Also, a pronounced increase was seen in the peaks assigned to glutamate and glutamine. This was confirmed by high field spectra ( 11* 5 T) obtained from tumour extracts. A 40 year old man suddenly developed headache with altered sensation in his right leg, lasting several hours. The next day he woke with loss of his right visual field. On examination he had a macular sparing right homonymous hemianopia. CT showed an infarct in the medial aspect of the left occipital lobe; Doppler scan and an MRI angiogram showed a stenosis in the left internal carotid. Subintimal thrombus was found on conventional MRI.
The vertebral arteries were normal in both patients.
Stroke in posterior cerebral artery territory can result from internal carotid artery disease; it is important to be aware of this when assessing patients with cerebrovascular disease. The three most severely affected patients presented before the moderately affected patients-as inevitably happens in most outbreaks. They rapidly developed a flaccid tetraplegia and initially had extensor plantar responses. EMGs failed to show pathognomonic incremental responses and low compound muscle action potentials (CMAPs) were suggestive of conduction block of peripheral neuropathic type. This led to some diagnostic confusion in the early stages.
As the outbreak progressed more classical findings were obtained and the neuromuscular transmission defect was best shown by postcontraction facilitation of the amplitude of compound muscle action potentials. Upper limb somatosensory evoked potentials in seven patients were entirely normal even though three patients showed lower limb pyramidal signs. Neurological deterioration and abnormalities on MRI may occur in adults with phenylketonuria (PKU) in whom diagnosis is delayed or who have poor dietary control. Proton magnetic resonance spectroscopy (MRS) has been carried out on five adult patients with PKU and abnormalities on MRI and in eight healthy, age matched controls. MRI showed diffuse high signal abnormalities on T2 weighted images in all patients. Spectra collected at echo times of 10 and 135 ms showed normal NAA/ creatine ratios (2-2 (SD 0-31)) in areas of MRI abnormality and from areas of normal appearing white matter (NAWM) compared with controls (1-88 (SD 0-18). Choline/creatine ratios were increased in the MRI lesions (1-16 (SD 0 3)) and in areas of NAWM (1-14 (SD 0-1) compared with control white matter (0-92 (SD 0 07)). Inositol/creatine ratios were reduced in lesions (0-47 (SD 0 2)) relative to control white matter (0-62 (SD 0 2)). No abnormal peaks attributable to phenylalanine or myelin breakdown products were seen.
The preservation of the NAA/creatine ratio suggests that little axonal loss is occurring within the MRI visible abnormalities in PKU whereas the raised choline/creatine ratio suggests increased membrane synthesis. The absence of myelin breakdown products also suggests that active myelin breakdown is not prominent.
The MRS findings in PKU support a non-destructive pathological process with increased membrane/myelin turnover. Magnetic resonance spectroscopy (MRS) was used to detect abnormalities of white matter and lesions in patients with multiple sclerosis and to examine the relation between disability (EDSS) and the biochemical parameters obtained with MRS.
MRS and two dimensional spectroscopic imaging were performed on a Philips 1-5 T S15/ACS MR imager. The nominal voxel size was 0-84 ml. The levels of N-acetylaspartate (NAA), cholines, and creatines were each expressed as fractions of the sum of these substances. The data of all voxels containing normal white matter (NWM, controls), normal appearing white matter (NAWM, patients), or multiple sclerosis lesions were pooled and these three datasets were compared. Furthermore, the average signal intensities of NAA, cholines, and creatines were measured in individual patients.
Eleven patients (four relapsing-remitting, five secondary progressive, two primary progressive) and three healthy controls were studied. The NAA fractions in pooled voxels of NWM were significantly higher (p < 0-001). Reduction of NAA is considered to be indicative of axonal and neuronal loss. The following findings were interesting: there was a significant correlation between the disability (EDSS) of individual patients and their ratio of NAA in NAWM and in lesions. A similar result appeared when the relapsing-remitting and secondary progressive patients were compared. The latter phenomenon does not indicate a fundamental biochemical difference between the two types of multiple sclerosis but reflects the increased EDDS in secondary progressive patients. Three questions with four responses ("never", "rarely", "often", and "routine" or "never", "once", "twice", or "more") relating to checking a full blood count (FBC) Respiratory regulation by the CNS involves automatic control from medullary respiratory centres and voluntary control via corticospinal pathways. The "locked in syndrome" (LIS) isolates medullary respiratory centres from rostral influences passing in the ventral pons with the corticospinal tracts. Respiratory variables during resting wakefulness were studied in a 44 year old man with LIS due to bilateral ventral pontine infarction five months postictus when he was breathing spontaneously via a tracheostomy. Results were compared with data from five tracheotomised control subjects. Variability about the mean in the patient with LIS was significantly less than in controls for T,, TE, V,, and PETCO2-Ventilatory sensitivity to CO2 was 1-7 1/min/ mm Hg (normal 1-5-3-8). In the patient with LIS the mean resting PFCO, was 39 0 mm Hg and prolonged apnoea occurred when PETCO2 was <38-0 mm Hg. Although completely unable to regulate respiratory muscle activity voluntarily, when he was amused he laughed and altered his respiratory rate and volume.
REMOTE MEMORY IN EARLY ALZHEIMER'S
These findings confirm that "isolated" human respiratory centres produce a very regular respiratory rhythm upon which variability is superimposed by separate descending systems mediating volitional and emotional control. They also show that medullary respiratory centres retain normal sensitivity to CO2 and that resting PETCO2 is held extremely close to the apnoeic threshold. those in EOM, an exception being the genetic findings. In 13 patients with LOM and in 16 patients with EOM a point mutation at nucleotide position 3243 in muscle mitochondrial DNA was present. The amount of mutated mtDNA was determined in 10 out of the 13 and in 11 out of the 16; it ranged from 50 to 95% in LOM and 56 to 95% in EOM, the overall amount of mutated mtDNA being significantly lower in LOM (p = 0 03 t test).
MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES (MELAS) IN ADULTS: A REPORT OF THREE CASES AND
It is concluded that LOM differs from EOM only in a genetic aspect with lower amounts of mutated mtDNA in LOM than EOM. These findings suggest that the age of onset may depend on the amount of mutated DNA.
LUMINANCE AND CHROMATIC CONTRAST SENSITIVITY IN ANTERIOR ISCHAEMIC OPTIC NEUROPATHY
W Honan, G Naylor. The Midland Centre for Neurosurgery and Neurology, Birmingham, UK A computer based system was used to measure luminance and chromatic spatial contrast sensitivity. Red and green sine wave gratings, of about equal luminance, produced a luminance (in phase) stimulus and a chromatic (antiphase) stimulus. The stimulus field was circular, 8°diameter, and mean luminance 35 cd m-2. It was presented on a uniform yellow, rectangular background field of equal luminance, 10°v ertical by 14°horizontal.
Ten cases of anterior ischaemic optic neuropathy (AION), were studied (median Snellen acuity 6/12, range 6/5-6/36) and compared with an age matched control group (median acuity 6/6, range 6/5-6/9). Fixation was central. Uniocular contrast sensitivity measurements were made, by the method of limits, at 1, 4, and 16 c/deg.
The results for chromatic contrast sensitivity showed mean losses in the AION group compared with the control group of 0-95 log units at 1 c/deg (p < (ATP) in specific areas of the brainstem, neocortex and allocortex is correlated with clinical findings of depression, changes in cognitive state, and neurobehavioural abnormalities. Lewy bodies of variable density and localisation were found in the neocortex of all subjects. ATP was found in 14 subjects but a diagnosis of Alzheimer's disease on the basis of the Khachaturian and CERAD criteria could be made in only five. It was possible to stage the Alzheimer's disease changes according to the Braak and Braak criteria in no more than 17 subjects. The three subjects in the isocortical stage all had clinical dementia, but this was present in only four of the six subjects in limbic stages III and IV. Two subjects in whom clinical dementia was associated with CLBs had no trace of ATP.
Although the number of patients in the study was small, the existence of a specific clinicopathological entity in patients with Parkinson's disease and CLBs could not be confirmed. NO The mean FIM and ESS improved from 62 and 19 on admission to 72 and 17 respectively at discharge. 90% and 47% of patients improved on the FIM and ESS respectively during their stay. Forty four patients were re-examined after three months; 62% had maintained or increased their functional abilities. The mean FIM and ESS was 70 and 17 respectively. 19 patients showed some neurological deterioration, of whom 10 suffered relapse, although only two showed deterioration on the EDSS. The mean change in FIM and ESS in those who had deteriorated was -6-2 and -04 respectively, and 0-2 and 1 0 in those who were unchanged.
In summary, whereas a third of patients had further clinical activity resulting in a deterioration in disability and handicap, function was maintained in most patients three months after discharge. It is concluded that PN occurs relatively often in patients with cancer and has not been found to be part of a polyneuropathy; it was related to weight loss. Cancer more often occurs in patients with than without PN, particularly in elderly men, even if corrected for the relation between age and cancer. PN in patients with cancer is supposed to be due to a combination of metabolic and mechanical factors. The results justify a prospective study on the relation between PN and cancer. Vigabatrin (y-vinyl-GABA or GVG) is used in refractory epileptic seizures, particularly complex partial fits. Due to irreversible inhibition of ,-aminobutyric acid transaminase (GABA-T) GVG increases the brain concentration of the inhibiting neurotransmitter GABA. Three patients are reported who developed a severe status epilepticus (SE) during GVG treatment.
Case I: A 17 year old woman with a spastic tetraparesis, generalised epilepsy and myoclonic jerks, and moderate mental handicap had two previous episodes of SE. Another episode of SE followed introduction of GVG (200 mg/day), cessation of DPH and tapering of PB. GVG was tapered in five days whilst thiopentone was administered over a period of 21 days. On PB and CZP she slowly regained consciousness but some myoclonic jerks remained; she was worse than before admission. Nerve conduction tests showed axonal polyneuropathy. She died due to probable pneumonia. A tentative diagnosis of neuroaxonal dystrophy could be made, necropsy was not performed.
Case II: A 16 year old woman had partial seizures after surgery for a frontoparietal fibrosarcoma and radiotherapy. After several years treatment with DPH and CBZ she relapsed. DPH was replaced by GVG and CBZ increased. A few months later she developed SE, which recurred daily for 10 days. GVG was stopped after five days. Four days later she had only minor frequent seizures on DPH, CBZ, and CZP.
Case III: A 33 year old, mentally handicapped, female patient had tonic-clonic and complex partial seizures from age 4. On oxcarbazepine (OCB) and clobazam she had seizures on average 0-5-1-0 per 24 hours. GVG was introduced and OCB tapered. While on 2000 mg GVG and 300 mg OCB, she developed a generalised convulsive SE lasting 13 hours and stopped by iv infusion of propofol; GVG was discontinued.
Exacerbation of seizures has been described occasionally for DPH, CBZ, and benzodiazepines. SE during GVG treatment could either be a coincidence or due to a possible disinhibiting effect of GABA in the nigrocollicular pathway by GVG. Based on data from serial monthly gadolinium enhanced brain MRI of 23 untreated patients with multiple sclerosis, sample sizes have been calculated for a treatment trial in which reduction in MRI activity is the primary measure of outcome. In a study of six months duration with a parallel group, placebo controlled design, a 70% reduction in the number of active lesions was seen with a greater than 90% power in 2 x 40 patients.
Because such a study requires far fewer patients and shorter follow up time than phase three clinical studies it is an excellent way of screening new treatments. It is not definitive, however, because of the uncertain relation between changes in MRI and long term clinical outcome.
This protocol is currently being used in the study of monoclonal CD4 antibodies. Seventy two patients with clinically active multiple sclerosis after either relapsing remitting or secondary progressive course have been randomly allocated to receive either 50 mg of chimaeric CD4 antibody (Centocor, or placebo monthly for six months. Active treatment resulted in a pronounced and rapid reduction in the peripheral blood CD4-count, which subsequently increased, although it remained below the normal range for at least a number of months after treatment. MRI evaluation will be in the second half of 1994.
DOMINANT MIGRATORY NEUROPATHY WITH CHROMOSOME 17 DELETION BRF Lecky, PK Thomas, J Tyson, S Malcolm. Walton Centre, Liverpool and Royal Free Hospital School of Medicine, and Institute of Child Health, London, UK A 66 year old man had had brief scalp pains since his 20s, often with an electric shocklike quality. In his late 50s he developed migratory trunk and limb pains, at times severe, in variable and localised areas but sparing the extremities. Episodes lasted between several hours and a few days with prolonged symptom free intervals. The pain was not associated with numbness and episodes were not provoked by stretch or trauma. The patient's father and sister are similarly affected and a son and daughter have developed scalp pains in their 30s.
Neurological signs were confined to loss of tendon reflexes and mild impairment of 2 point discrimination. Motor conduction velocities were normal. Sensory action potentials were very small with normal or mildly reduced sensory conduction velocities. Sural nerve biopsy showed reduction in the number of small myelinated axons. Examination of CSF was normal.
Analysis of DNA showed a chromosome 17p deletion, which is now known to be the basis for hereditary liability to pressure palsies. It is becoming clear that phenotypic expression of this condition is varied and unexpected. Although this family shows a superficial similarity to Wartenburg's syndrome, this condition is sporadic and is not known to have autosomal dominant inheritance.
AXON FLARE RESPONSE IN PERIPHERAL NEUROPATHIES
AC Mann, GA Jamal. Southern General Hospital, Glasgow, UK. (Introduced by JP Ballantyne)
The axon flare response is a neurally mediated rise in skin blood flow that occurs secondary to a noxious stimulus. Current evidence suggests that it is largely dependent on the integrity of the polymodal nociceptive group C nerve endings and therefore gives a potential method by which this group of fibres can be assessed. This is important as current routine neurophysiological tests fall short of such an assessment. The purpose of this study was to compare the axon flare response as measured by laser Doppler flowmetry in normal controls and patients with peripheral neuropathies. The flare was induced by applying standardised electrical pulses to the dorsum of the hand and foot. Twelve age and sex matched subjects were included in each group and patients with diabetes mellitus were excluded due to their risk of vascular disease. The area of the lower limb response was significantly reduced in the neuropathy group (244 V/min) compared with the controls (1099 V/min); p < 0 05). No significant difference was found in the upper limb responses. These results suggest that this technique will be of use in the study of various neuropathic conditions and further work is indicated particularly in patients in whom pain is a prominent symptom. Nine AVMs (75%) were successfully imaged (Spectra, Diasonics Inc), three being visualised with "ultrasound angiography". Principal AVM feeder vessels were identified in 11 cases (seven middle cerebral artery, two posterior cerebral artery, one anterior cerebral artery, one basilar artery). intracerebral tumours presenting with epilepsy, primarily designed for patients with low grade gliomas (LGGs). The SE Scotland Brain Tumour Register was analysed to determine the accuracy of the MRC(BR08) criteria and to see if postcontrast non-enhancement (PCNE) on CT increased specificity for LGGs.
MRC(BR08) identifies adult patients with CT evidence of a glioma who present with epilepsy without neurological signs or history of malignancy as being suitable for randomisation. Their criteria were applied to a database of incident cases of brain tumour diagnosed in 1989-90.
One hundred and five of 580 patients with intracranial brain tumours presented with epilepsy over a two year period. Twenty four (23%) patients satisfied the criteria for randomisation for MRC(BR08): fourteen patients with LGG (10 histologically proved), nine high grade glioma (seven anaplastic astrocytoma, two glioblastoma multiformi), one undiagnosed tumour type. The inclusion of PCNE on CT identified 11 patients with LGGs (eight histologically proved) and one patient with anaplastic astrocytoma.
Thirty nine per cent of patients satisfying MRC(BR08) criteria had high grade gliomas. These would commonly be treated with early surgery and radiotherapy. The inclusion of PCNE on CT increased the specificity for LGGs. Autosomal dominant diseases provide a unique opportunity to study the evolution of a pathological condition. The earliest clinical manifestations may be seen in longitudinal assessments of presymptomatic subjects "at risk". This methodology has been applied to investigate familial Alzheimer's disease.
A 43 year old woman "at risk" from a pedigree of necropsy-confirmed familial Alzheimer's disease was assessed on a comprehensive battery of neuropsychological tests in 1991 and subsequently these tests were repeated in early 1992 and late 1992. These assessments included intelligence tests, and tests of memory, language, literacy skills, and perceptual functions. The selection of tests was determined by the availability of standardised scores so that performance across cognitive skills could be compared.
At the first and second assessment she was presymptomatic and at the second and third assessment her scores on the MMSE were still entirely normal (30/30 and 29/30). On neuropsychological assessment, however, a distinctive pattern of cognitive impairment was shown at the first assessment and progression of these deficits over the subsequent two assessments. These findings show that neuropsychometric methods have an important role in the early diagnosis and delineation of cognitive deficits in degenerative conditions. Lower urinary tract dysfunction is a major cause of morbidity in multiple sclerosis. al Adrenergic receptors are present in the bladder neck where increased adrenergic activity may contribute to diminished flow rates and urinary retention. Indoramin is a selective al adrenergic receptor antagonist. A randomised, placebo controlled study was performed to test the hypothesis that indoramin would improve bladder emptying in multiple sclerosis. Urinary function was assessed by measurement of peak and mean urinary flow rates, residual volume by ultrasound, and symptom score. The active treatment was 20 mg indoramin twice daily. Eighteen men (of 41 assessed initially) were evaluated at entry to the trial and again after four weeks of treatment.
There was a mean percentage improvement in peak flow rate of 41% in the indoramin group compared with -7-4% in the placebo group (p < 0-05). There was no difference in residual urinary volumes between the two groups but patients taking indoramin reported a greater improvement in urinary symptoms. Modulation of the al receptor may have a part to play in the management of urinary dysfunction in multiple sclerosis. Stroke Project has examined a bipolar district (population 305 000) without a stroke policy to estimate the 1991 expenditure on stroke and to define its component parts of prevention, acute care, and rehabilitation.
The estimated total cost of 2 859 000 represented 3-1% of the annual budget, with nearly two thirds spent on chronic care and only a small fraction, £77 000, mostly for anticoagulation, on prevention. Inpatient costs, spread equally between acute and non-acute beds, accounted for 60% of the budget. The mean duration of stay was 30 days of which 10 were spent in acute wards (cost £161 per day), and the remainder in non-acute beds, (£66 per day)-that is, £3000 per admission.
Nursing and infrastructure costs for both in and outpatients consumed 80% of the revenue, district nursing accounting for £689 000. In sharp contrast only £121 000, 4% of the budget, was spent on paramedical treatment.
Up to 60% of strokes are preventable and there is now good evidence that organised rehabilitation improves outcome. The findings presented here suggest that in the absence of a coherent strategy much of the current expenditure on stroke is inefficient and poor value for money. Six patients with past demyelinating optic neuritis and five healthy age and sex matched controls were studied. All had temporal modulation sensitivities at different temporal frequencies in the form of DeLange attenuation curves using three kinds of flickering stimuli with different spatial configurations. The mean threshold sensitivities for the control group were subtracted from the mean thresholds of the individual patients and the losses in the log modulation sensitivities were then calculated.
All patients had MRI of the optic nerves using STIR (2000/150/40) Most studies show a high sensitivity of MRI in the diagnosis of multiple sclerosis, but a rather low specificity. An attempt to improve the specificity of MRI is reported.
Patients (n = 57) with monophasic neurological symptoms suggestive of multiple sclerosis were studied prospectively with MRI shortly after the onset of symptoms (mean interval five weeks). A spinal tap was performed in 34 patients. Clinically definite multiple sclerosis was diagnosed when new symptoms in other parts of the CNS occurred (mean follow up 13 months).
So far, multiple sclerosis developed in 17 patients (35%). Other diagnoses were made in nine patients, and 31 patients remain without a diagnosis. Examination of CSF had a sensitivity of 69% and a specificity of 38%. When four or more MRI lesions were required (Paty criteria), the sensitivity was 94% and specificity 55%; with nine or more lesions these percentages were 88 and 75 respectively. Gadolinium enhancement increased specificity to 80%, although sensitivity dropped to 55%. The presence of an infratentorial lesion (Fazekas) had a sensitivity of 82% and a specificity of 80%.
This prospective study shows that the specificity of MRI can be considerably increased by requiring either nine instead of four lesions, an enhancing lesion, or an infratentorial lesion. Conjugate eye deviation (CED) in patients with supratentorial stroke is generally directed ipsilateral to the lesioned hemisphere. Incidentally, CED occurs to the contralateral side, also designated as wrongway eyes. Five new cases are reported and previously published reports are reviewed to elucidate the lesion responsible and the mechanism underlying this phenomenon.
In a prospective study of 133 consecutive patients with CED caused by an acute supratentorial stroke, five patients had contralateral CED. These five patients were studied clinically; in four patients CT was performed. Four of the five patients died and necropsy was performed in all four of them.
In four patients contralateral CED was caused by an intracerebral haemorrhage located thalamic (n = 2), frontoparietal (n = 1), and frontoparietotemporal (n = 1). In one the cause was a subdural haematoma. All patients had clinical signs of rostral midbrain dysfunction and a shift of midline structures on CT or at necropsy. Necropsy showed no additional destructive lesions in the other hemisphere or brainstem, except for one patient who showed a demyelination of the medial part of the cerebral peduncle ipsilateral to the thalamic haemorrhage at midbrain level, at microscopical examination.
It is concluded that contralateral CED is always associated with haemorrhagic lesions, most commonly in the thalamus. The prognosis of patients with this sign is generally poor. Involvement of descending oculomotor pathways from the contralateral hemisphere at the midbrain level is the most probable explanation for the phenomenon. Apart from adults and adolescents with brachial plexus lesions, in this hospital more than 250 children were seen with an obstetric brachial plexus lesion and still severe paresis after several months. As about 90%-95% recover within a short time, this group represents a total cohort of about 2500-5000 neonates with an obstetric brachial plexus lesion.
In adults and adolescents, the EMG findings closely mimic the clinical picture and give reliable information about the severity and location of the lesion. In neonates, the EMG findings are different and mostly much more "optimistic" than the clinical lesion.
One of the most striking differences is the finding of a mixed interference pattern in the EMG in a muscle that is clinically completely paralysed. Sometimes painful stimuli are needed for this finding. This was found in more than half of the children. Therefore, the paralysis in these children cannot be explained by the peripheral lesion alone. The same was found by McComas in one child, using his motor-unit counting technique.
This leads to the conclusion that changes in the CNS, either induced by or resulting from the lesion in the peripheral nervous system, may play an important part in children with an obstetric brachial plexus lesion. CORRELATION Patients with multiple sclerosis (n = 48) were examined twice clinically (EDSS) and with MRI (mean interval 24 (range 10-42) months). MRI (spin echo sequences) included T2 weighted images in all and Tl weighted images in 18 patients, which were computer quantified with a seed growing technique. An increase in EDSS correlated with increase in T2 weighted lesion load (r = 0 53, p < 0-0001), whereas the subgroup with TI weighted images showed a significant correlation of increase in EDSS and area of decreased signal intensity (r-0-89, p < 0-0001).
It is concluded that short duration of follow up might explain the weak relation between increase in disability and T2 lesion load (25% variance explained). More probably T2 weighted images also detect areas of oedema and mild demyelination, which are still functionally intact, whereas areas of decreased signal intensity on TI weighted images represent only severe demyelination, pronounced gliosis, and axonal loss, having little residual function; hence the strong correlation with increase in EDSS (80% variance explained). (137 vessels) , were reported by two experienced neuroradiologists. Each angiogram was assessed blind and independently,-by recording the visual impression of the degree of stenosis. One radiologist reported all the angiograms a second time, enabling full analysis of the inter and intraobserver variation in reporting. A separate analysis was performed with calipers by one of the authors (GY), who measured the minimum residual lumen of the internal carotid artery as numerator and the maximum diameter of the distal common carotid artery as denominator, these being hard, objective measurements.
For interobserver variation, the means of the absolute differences between assessments were 7 0% for DSA and 6-4% for MRA. Corresponding results for intraobserver variation were 5-7% and 7-7%. Intraobserver mean absolute differences with caliper measurements were 3 0% for DSA and 3-5% for MRA. Clinically important differences occurred in 5-5% (DSA) and 4-1% (MRA), due to interobserver variation, and in 5-3% (DSA) and 5-3% (MRA) because of intraobserver variation. Intraobserver variation in caliper readings resulted in clinically important differences in 3-1% (DSA) and 1-6% (MRA).
Observer variation in reporting MRA is similar to that for DSA, and can result in clinically significant differences. Caliper measurements would seem to be more consistent.
